Cancer drugs show promise to fight autoimmune diseasesNovember 14th, 2007 - 2:23 am ICT by admin
Working with his colleagues, he has now discovered that HDAC inhibitors stimulate a specific class of immune cells called regulatory T-cells, which control the activity of other immune cells, including rogue T-cells.
They have found in tests on mice that HDAC inhibitors suppress inflammatory bowel disease and prevent rejection of heart and pancreatic grafts, reports the New Scientist.
Dr. Hancock thinks that HDAC inhibitors might have caused this effect by boosting both the number of regulatory T-cells and the amount of Foxp3, a messaging molecule they produce.
This surfeit of Foxp3 in turn suppresses the immune response of T-cells, he says. (ANI)
- Cell population responsible for body's immune response identified - Mar 07, 2011
- 'Master switch' for key immune cells in inflammatory diseases found - Jan 17, 2011
- Proteins' absence causes diabetes, rheumatoid arthritis - Sep 10, 2012
- Cancer drug can reverse heart failure - May 31, 2011
- Human body can create its own vaccine to boost the immune system - Dec 15, 2010
- Compound that effectively suppresses multiple sclerosis developed - Apr 19, 2011
- Killer white blood cells could make organ rejection history - Aug 22, 2010
- Researchers cure type 1 diabetes in mice - Apr 09, 2010
- Molecular 'playbook' to stop heart failure risk factor found - Sep 24, 2010
- Scientists develop rare cells in lab to counter autoimmune diseases - Nov 04, 2009
- New probiotic fights inflammatory bowel diseases - Feb 01, 2011
- Eye colour linked to severity of skin conditions - May 07, 2012
- Super microscope helps pinpoint our immunity 'switch' - Jun 06, 2011
- Cancer drug may help treat arthritis, multiple sclerosis - Jul 01, 2010
- Possible onset mechanism for multiple sclerosis discovered - Feb 27, 2010
Tags: autoimmune diseases, cancer drugs, foxp3, grafts, hdac, immune cells, immune response, immune system, inflammatory bowel disease, molecule, nature medicine, new scientist, overdrive, regulatory t cells, rejection, surfeit, wayne hancock